XableCath’s peripheral arterial cathetersJuly 2, 2018
XableCath, Inc has been granted a second US patent covering its XableCath catheter.
The patent specifically describes a catheter that controls tissue contact and has a rigid ring implement that opens a blood vessel occlusion by rotating the ring against the occlusion, thus clearing the vessel and providing access across the lesion.
“Our proprietary design enables the XableCath to easily slide past an occluding atheroma through the true lumen of the vessel,” stated XableCath president and chief executive officer, Lisa Dunlea.
The innovative and unique design enables a safe and rapid passage of catheter through chronic peripheral total occlusions, both above and below the knee.
The XableCath support catheter is designed to treat peripheral arterial disease (PAD) by facilitating over-the-wire passage through the true artery lumen, enabling endovascular treatment options such as angioplasty, stenting, or atherectomy.
XableCath was founded in 2014 to commercialize catheters for the treatment of vascular disease.